Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient Monitoring
About this episode
This episode discusses fecal microbiota therapy, focusing on clinical laboratory testing and metabolomic approaches for donor screening, product assessment, and patient monitoring.
Grace Drew, Colleen S Kraft, Nirja Mehta. Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient Monitoring. Clinical Chemistry , Volume 72, Issue 5, May 2026, Pages 554–563. https://doi.org/10.1093/clinchem/hvaf156
More episodes of Clinical Chemistry Podcast
- From Pooled Cohorts to PREVENT: A Perspective for Clinical Laboratorians
- Disseminated Coccidioidomycosis in Immunocompetent Hosts: Opportunities for Increased Recognition and Timely Diagnosis
- Audio Summary July 2026
- DPYD Sequencing Identifies More Clinically Relevant Variants as Compared to Targeted Genotyping
- Universal Presence of Gene/Variant Nomenclature Errors in Journal Manuscript Submissions
- Frameworks of Health Outcomes for Performance Specifications in Laboratory Medicine
Explore listener stats, chart rankings, contacts and more on the Clinical Chemistry Podcast podcast page.